E-DRUG Archives (by date)

• Thread Index

June 30, 2002
• [e-drug] Antidepressants and 'miracle drug' label
  • From: E-drug <e-drug@usa.healthnet.org>
• [e-drug] Street vending of drugs in Africa
  • From: richardl@bu.edu
• [e-drug] Imports of generics in francophone Africa
  • From: catherinegavin@bluewin.ch
June 28, 2002
• [e-drug] Re: Sources and prices of HIV/AIDS drugs and diagnostics
  • From: Mary Ojoo <mojoo@gerties.org>
June 27, 2002
• [e-drug] G8 & global health crises: press release
  • From: relliott@aidslaw.ca
• [e-drug] Where is the 10 billion dollars?
  • From: Act Up-Paris <ojablonski@free.fr>
• [e-drug] Satellite Financing Care for PLWH, 6 July Barcelona
  • From: "Renaud-Thery, Francoise" <theryf@unaids.org>
• [e-drug] Sources and prices of HIV/AIDS drugs and diagnostics
  • From: e-drug@usa.healthnet.org
June 26, 2002
• [e-drug] Important paper on Doha Declaration
  • From: Pascale_BOULET@msf.org
June 25, 2002
• [e-drug] MSF's article in Le Monde on post Doha
  • From: Pierre CHIRAC <pierchir@club-internet.fr>
• [e-drug] US framework to increase access
  • From: e-drug@usa.healthnet.org
• [e-drug] Petition EU Directive/la revue Prescrire
  • From: "Christophe Kopp" <Christophe.Kopp@wanadoo.fr>
• [e-drug] NYTimes: U.S. Backs New Trade Rules on Drugs
  • From: e-drug@usa.healthnet.org
• [e-drug] Dutch gov't may stop monitoring advertising & marketing activities
  • From: lisa@haiweb.org
June 21, 2002
• [e-drug] Drug development for neglected diseases
  • From: e-drug@usa.healthnet.org
• [e-drug] BMJ: Breast is still best even when HIV prevalence is high
  • From: e-drug@usa.healthnet.org
• [e-drug] WTO chief targets multinationals
  • From: e-drug@usa.healthnet.org
• [e-drug] Pfizer sues to block generic Diflucan
  • From: e-drug@usa.healthnet.org
• [e-drug] A Whistle-Blower Rocks an Industry
  • From: "Sidney Wolfe" <SWOLFE@citizen.org>
June 19, 2002
• [e-drug] New ORS formulation
  • From: Beverley Snell <bev@burnet.edu.au>
June 17, 2002
• [e-drug] Re: Conflict of Interest? (cont)
  • From: "Jon Rohde" <JonRohde@equityproject.co.za>
• [e-drug] Re: Quality use of Medicines in Australia (cont)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise (cont)
  • From: "Bonnie Fundafunda" <bfunda@echohealth.org.uk>
June 15, 2002
• [e-drug] UK consumers reject direct advertising by drug industry
  • From: E-drug <e-drug@usa.healthnet.org>
June 14, 2002
• [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise (cont)
  • From: "Trouiller, Patrice" <PTrouiller@chu-grenoble.fr>
• [e-drug] Re: Conflict of Interest?
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise (cont)
  • From: Pauldspivey@aol.com
• [e-drug] Re: New body [....] clinical trial ethics in developing world
  • From: Jsavirimuthu@aol.com
• [e-drug] Conflict of Interest?
  • From: "Sidney Wolfe" <SWOLFE@citizen.org>
June 13, 2002
• [e-drug] Re: Handheld computers in resource-poor settings (cont)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] Promoting Rational Drug Use in the Community (PRDUC)
  • From: hogerzeilh@who.ch
• [e-drug] Re: Iatrogenic HIV in Africa
  • From: "Trouiller, Patrice" <PTrouiller@chu-grenoble.fr>
• [e-drug] Re: Handheld computers in resource-poor settings (cont)
  • From: Leela McCullough <leela@usa.healthnet.org>
• [e-drug] Re: Pharmaceutical Innovation in a Global Economy
  • From: "Nancy Blum" <NLB@usp.org>
June 12, 2002
• [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise (cont)
  • From: "Johnson,Keith" <kjohnson@msh.org>
• [e-drug] Course: Managing Drug Supply for Primary Health Care
  • From: "Miralles,Maria" <mmiralles@msh.org>
• [e-drug] EU and TRIPS
  • From: Jsavirimuthu@aol.com
• [e-drug] Iatrogenic HIV in Africa
  • From: Hilbrand Haak <haakh@chd-consultants.nl>
June 11, 2002
• [e-drug] Re: New body [....] clinical trial ethics in developing world
  • From: Frank Webb <FWebb@FHI.org>
• [e-drug] New body to oversee clinical trial ethics in developing world
  • From: sfoster@bu.edu
June 10, 2002
• [e-drug] Re: Handheld computers in resource-poor settings (cont)
  • From: "Bonnie Fundafunda" <bfunda@echohealth.org.uk>
• [e-drug] Re: Quality use of Medicines in Australia
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Re: Handheld computers in resource-poor settings
  • From: "Jon Rohde" <JonRohde@equityproject.co.za>
June 08, 2002
• [e-drug] Clinical Pharmacy Conference in Malaysia 22-23 July
  • From: snling@imu.edu.my
• [e-drug] International Clinical Pharmacy Symposium Malaysia
  • From: snling@imu.edu.my
• [e-drug] Quality use of Medicines in Australia
  • From: Libby Roughead <Libby.Roughead@unisa.edu.au>
• [e-drug] Handheld computers in resource-poor settings
  • From: Leela McCullough <leela@usa.healthnet.org>
• [e-drug] Re: NYT: New Drug for Malaria Pits U.S. Against Africa
  • From: Kibumba George <kibumba@yahoo.com>
June 07, 2002
• [e-drug] Re: Evergreening of patents (cont)
  • From: "Barbara Mintzes" <bmintzes@telus.net>
• [e-drug] Re: Evergreening of patents
  • From: Jsavirimuthu@aol.com
• [e-drug] Evergreening of patents
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise (cont)
  • From: Jsavirimuthu@aol.com
June 06, 2002
• [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise (cont)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• [e-drug] Zimbabwe HIV emergency
  • From: Beverley Snell <bev@burnet.edu.au>
• [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise (cont)
  • From: David Henry <mddah@mail.newcastle.edu.au>
• [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise
  • From: Beverley Snell <bev@burnet.edu.au>
June 04, 2002
• [e-drug] MSH-Bill Gates Foundation Essential Medicines Franchise
  • From: "Trouiller, Patrice" <PTrouiller@chu-grenoble.fr>
• [e-drug] new WHO/EDM Executive Director
  • From: e-drug@usa.healthnet.org
• [e-drug] MSF/HealthGAP meeting in Barcelona
  • From: julia_double@geneva.msf.org
June 03, 2002
• [e-drug] Re: Cryptosporidiosis
  • From: Jsavirimuthu@aol.com
• [e-drug] Zimbabwe anti-retroviral patents page
  • From: WilbertBannenberg@compuserve.com
• [e-drug] Disclosure of info as foundation for developing new medicines
  • From: Jsavirimuthu@aol.com
• [e-drug] Kenya: guidelines to end inappropriate use of painkillers
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Antibiotic use study
  • From: Beverley Snell <bev@burnet.edu.au>
• [e-drug] Magnesium sulphate for pre-eclampsia
  • From: Beverley Snell <bev@burnet.edu.au>